SE9704693L - Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor - Google Patents

Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Info

Publication number
SE9704693L
SE9704693L SE9704693A SE9704693A SE9704693L SE 9704693 L SE9704693 L SE 9704693L SE 9704693 A SE9704693 A SE 9704693A SE 9704693 A SE9704693 A SE 9704693A SE 9704693 L SE9704693 L SE 9704693L
Authority
SE
Sweden
Prior art keywords
human
mastitis
type
prophylactic treatment
mothers
Prior art date
Application number
SE9704693A
Other languages
Unknown language ( )
English (en)
Other versions
SE9704693D0 (sv
SE511237C2 (sv
Inventor
Aake Lignell
Johan Inborr
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9704693A priority Critical patent/SE511237C2/sv
Publication of SE9704693D0 publication Critical patent/SE9704693D0/sv
Priority to JP2000538684A priority patent/JP2002508318A/ja
Priority to CA002314170A priority patent/CA2314170C/en
Priority to PCT/SE1998/002279 priority patent/WO1999030701A1/en
Priority to NZ504801A priority patent/NZ504801A/en
Priority to EP98963702A priority patent/EP1049460B1/en
Priority to DE69814467T priority patent/DE69814467D1/de
Priority to US09/589,594 priority patent/US6335015B1/en
Priority to AT98963702T priority patent/ATE239457T1/de
Priority to AU18972/99A priority patent/AU743198B2/en
Priority to ARP980106418A priority patent/AR017877A1/es
Publication of SE9704693L publication Critical patent/SE9704693L/sv
Publication of SE511237C2 publication Critical patent/SE511237C2/sv
Priority to NO20003042A priority patent/NO327301B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
SE9704693A 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor SE511237C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
AU18972/99A AU743198B2 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
DE69814467T DE69814467D1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
CA002314170A CA2314170C (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
PCT/SE1998/002279 WO1999030701A1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
NZ504801A NZ504801A (en) 1997-12-16 1998-12-10 A medicament containing one type of xanthophylis for the prophylactic treatment of mastitis
EP98963702A EP1049460B1 (en) 1997-12-16 1998-12-10 Method for the prophylactic treatment of mastitis
JP2000538684A JP2002508318A (ja) 1997-12-16 1998-12-10 乳腺炎の予防処置法
US09/589,594 US6335015B1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
AT98963702T ATE239457T1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
ARP980106418A AR017877A1 (es) 1997-12-16 1998-12-16 Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
NO20003042A NO327301B1 (no) 1997-12-16 2000-06-14 Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Publications (3)

Publication Number Publication Date
SE9704693D0 SE9704693D0 (sv) 1997-12-16
SE9704693L true SE9704693L (sv) 1999-06-17
SE511237C2 SE511237C2 (sv) 1999-08-30

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Country Status (12)

Country Link
US (1) US6335015B1 (sv)
EP (1) EP1049460B1 (sv)
JP (1) JP2002508318A (sv)
AR (1) AR017877A1 (sv)
AT (1) ATE239457T1 (sv)
AU (1) AU743198B2 (sv)
CA (1) CA2314170C (sv)
DE (1) DE69814467D1 (sv)
NO (1) NO327301B1 (sv)
NZ (1) NZ504801A (sv)
SE (1) SE511237C2 (sv)
WO (1) WO1999030701A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
CA2495167C (en) 2002-07-29 2018-08-21 Hawaii Biotech, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7691901B2 (en) 2004-04-14 2010-04-06 Cardax Pharmaceuticals Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
NZ554476A (en) 2004-09-28 2010-09-30 Chemaphor Inc Compositions and methods for promoting weight gain feed conversion
US20060088905A1 (en) * 2004-10-01 2006-04-27 Lockwood Samuel F Methods for the synthesis of zeazanthin
WO2009052629A1 (en) 2007-10-26 2009-04-30 Chemaphor Inc. Compositions and methods for enhancing immune response
CA2975313C (en) 2009-04-30 2020-06-30 Avivagen Inc. Methods and compositions for improving the health of animals
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
CA3168140A1 (en) * 2020-02-18 2021-08-26 Avivagen Inc. Supplemented animal feeds for mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
JPH10513444A (ja) * 1995-02-03 1998-12-22 ビーエーエスエフ アクチェンゲゼルシャフト 皮膚疾患の治療のための医薬品の製造のためのカロチノイドの使用
JPH09124470A (ja) 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
DE69814467D1 (de) 2003-06-12
US6335015B1 (en) 2002-01-01
CA2314170A1 (en) 1999-06-24
NO20003042L (no) 2000-06-14
NO20003042D0 (no) 2000-06-14
WO1999030701A1 (en) 1999-06-24
EP1049460B1 (en) 2003-05-07
ATE239457T1 (de) 2003-05-15
NO327301B1 (no) 2009-06-02
AU1897299A (en) 1999-07-05
CA2314170C (en) 2008-01-29
AR017877A1 (es) 2001-10-24
SE9704693D0 (sv) 1997-12-16
EP1049460A1 (en) 2000-11-08
JP2002508318A (ja) 2002-03-19
NZ504801A (en) 2002-05-31
AU743198B2 (en) 2002-01-24
SE511237C2 (sv) 1999-08-30

Similar Documents

Publication Publication Date Title
SE9704693L (sv) Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
BR0014563A (pt) Uso de fator de crescimento de transformação beta e fatores de crescimento anabólico, produto, e, composição farmacêutica
ATE243030T1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
CN1200036A (zh) 含有磷脂混合物并具有抗细胞程序死亡活性的组合物
DK1011653T3 (da) Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser
ES2061772T3 (es) Inhalante aerosol que comprende un ester de retinol y/o de acido retinico.
JPH11504899A (ja) 獣医学および医学用途用化合物
SE9704590L (sv) Sätt att öka produktionen av och förbättra kvaliteten hos sperma
EP0804227B1 (en) Use of lysozyme dimer for treating cancer
SE9803541D0 (sv) Treatment of dyspepsia
SE9704737D0 (sv) Immunoglobulin-rich milk, production and use thereof
KR101623553B1 (ko) 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
CA2405479A1 (en) Method of inhibiting the expression of inflammatory cytokines and chemokines
ES2112517T3 (es) Antibioticos ge 37468 a, b y c.
CN110724609A (zh) 一种小桐子油植物皂基及其制备方法
CN105519815A (zh) 一种用于提高鸡免疫力的饲料添加剂
Sethi Experimental sporotrichosis in the normal and modified host
CN1634569A (zh) 动物干扰素基因工程生物活性制剂
RU2034569C1 (ru) Биологически активный препарат для овец
RU2034571C1 (ru) Биологически активный препарат для норок
CN110664651A (zh) 一种治疗口腔粘膜修护的组合物及其制备方法
RU94031387A (ru) Способ повышения иммунного статуса цыплят путем сочетанного применения пробиотика и иммуномодулятора
JP2019147781A (ja) 小胞体シャペロン産生促進剤
RU94031260A (ru) Питательная среда для выделения и культивирования гонококка
JPH01207237A (ja) 腫瘍壊死因子誘起剤

Legal Events

Date Code Title Description
NUG Patent has lapsed